Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...

Swiss public transport company, Regionalverkehr Bern-Solothurn (RBS), made its debut in the public market on Thursday. The ...

Despite a challenging year with decreased revenue, Seer Inc (SEER) strengthens its market position through strategic ...

Ukraine has claimed to have destroyed a thermobaric weapons ammunition depot in the Russian-occupied territories overnight, ...

As tariffs loom, 3M spinoff Solventum’s operating margins are continuing to shrink, and its investors are looking toward the company’s announced purification business sale for balance sheet relief.

The global HIV diagnosis market, valued at US$2.96 billion in 2024, is forecasted to grow at a robust CAGR of 10.3%, reaching US$3.25 billion ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

The rising incidence of blood disorders and chronic illnesses, along with an increase in accidents and emergency care requirements, is fueling the demand for blood and blood products. Additionally, ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...